Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Uveal Melanoma 1Neoplasm Metastasis 1Melanoma 1Brain Neoplasms 1

Interventions

Melphalan 3tebentafusp 1sargramostim 1fotemustine 1aflibercept 1Ranibizumab 1Nivolumab 1Neoadjuvant Therapy 1Melatonin 1MART-1 Antigen 1Ipilimumab 1Eye Enucleation 1Dacarbazine 1Colony-Stimulating Factors 1Chemotherapy, Cancer, Regional Perfusion 1Brachytherapy 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Uveal Melanoma × fotemustine × Clear all
NCT00110123 2012-09-24

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
171 enrolled
Dermatologic

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡